# Diltiazem vs. Metoprolol in the Acute Management of AF in Patients With HFrEF

> **NCT02938260** · — · COMPLETED · sponsor: **RaeAnn Hirschy** · enrollment: 48 (actual)

## Conditions studied

- Atrial Fibrillation
- Heart Failure

## Interventions

- **DRUG:** Metoprolol vs Diltiazem

## Key facts

- **NCT ID:** NCT02938260
- **Lead sponsor:** RaeAnn Hirschy
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2018-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02938260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02938260, "Diltiazem vs. Metoprolol in the Acute Management of AF in Patients With HFrEF". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02938260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*